Tenofovir disoproxil is a nucleotide analogue reverse transcriptase inhibitor (NRTI) utilized in the treatment of HIV-1 infection and chronic hepatitis B. As a prodrug, it is designed to enhance the oral… Read more
Tenofovir disoproxil is a nucleotide analogue reverse transcriptase inhibitor (NRTI) utilized in the treatment of HIV-1 infection and chronic hepatitis B. As a prodrug, it is designed to enhance the oral bioavailability of its active form. Within the pharmaceutical and analytical chemistry fields, maintaining rigorous quality control is essential for ensuring product efficacy and safety. Laboratories utilize high-quality reference standards of tenofovir disoproxil, along with its specific impurities and metabolites, to conduct precise impurity profiling and method validation. Furthermore, stable isotope labelled compounds, such as deuterated analogues, are critical tools in liquid chromatography-mass spectrometry (LC-MS) and gas chromatography-mass spectrometry (GC-MS) workflows. These labelled standards function as internal standards to correct for matrix effects and variations in ionization, ensuring accurate quantification and reliable data during the rigorous testing of pharmaceutical batches and pharmacokinetic studies.